Research ArticleCARDIOVASCULAR
Up-Regulation of Heme Oxygenase Provides Vascular Protection in an Animal Model of Diabetes through Its Antioxidant and Antiapoptotic Effects
Adam L. Kruger, Stephen J. Peterson, Michal L. Schwartzman, Heidi Fusco, John A. McClung, Melvin Weiss, Sylvia Shenouda, Alvin I. Goodman, Michael S. Goligorsky, Attallah Kappas and Nader G. Abraham
Journal of Pharmacology and Experimental Therapeutics December 2006, 319 (3) 1144-1152; DOI: https://doi.org/10.1124/jpet.106.107482
Adam L. Kruger
Division of Cardiology (A.L.K., J.A.M., M.W.), Departments of Medicine (A.L.K., S.J.P., J.A.M., M.W., A.I.G., M.S.G.) and Pharmacology (M.L.S., H.F., S.S., N.G.A.), and Division of Nephrology (A.I.G., M.S.G.), New York Medical College, Valhalla, New York; and the Rockefeller University, New York, New York (A.K., N.G.A.)
Stephen J. Peterson
Division of Cardiology (A.L.K., J.A.M., M.W.), Departments of Medicine (A.L.K., S.J.P., J.A.M., M.W., A.I.G., M.S.G.) and Pharmacology (M.L.S., H.F., S.S., N.G.A.), and Division of Nephrology (A.I.G., M.S.G.), New York Medical College, Valhalla, New York; and the Rockefeller University, New York, New York (A.K., N.G.A.)
Michal L. Schwartzman
Division of Cardiology (A.L.K., J.A.M., M.W.), Departments of Medicine (A.L.K., S.J.P., J.A.M., M.W., A.I.G., M.S.G.) and Pharmacology (M.L.S., H.F., S.S., N.G.A.), and Division of Nephrology (A.I.G., M.S.G.), New York Medical College, Valhalla, New York; and the Rockefeller University, New York, New York (A.K., N.G.A.)
Heidi Fusco
Division of Cardiology (A.L.K., J.A.M., M.W.), Departments of Medicine (A.L.K., S.J.P., J.A.M., M.W., A.I.G., M.S.G.) and Pharmacology (M.L.S., H.F., S.S., N.G.A.), and Division of Nephrology (A.I.G., M.S.G.), New York Medical College, Valhalla, New York; and the Rockefeller University, New York, New York (A.K., N.G.A.)
John A. McClung
Division of Cardiology (A.L.K., J.A.M., M.W.), Departments of Medicine (A.L.K., S.J.P., J.A.M., M.W., A.I.G., M.S.G.) and Pharmacology (M.L.S., H.F., S.S., N.G.A.), and Division of Nephrology (A.I.G., M.S.G.), New York Medical College, Valhalla, New York; and the Rockefeller University, New York, New York (A.K., N.G.A.)
Melvin Weiss
Division of Cardiology (A.L.K., J.A.M., M.W.), Departments of Medicine (A.L.K., S.J.P., J.A.M., M.W., A.I.G., M.S.G.) and Pharmacology (M.L.S., H.F., S.S., N.G.A.), and Division of Nephrology (A.I.G., M.S.G.), New York Medical College, Valhalla, New York; and the Rockefeller University, New York, New York (A.K., N.G.A.)
Sylvia Shenouda
Division of Cardiology (A.L.K., J.A.M., M.W.), Departments of Medicine (A.L.K., S.J.P., J.A.M., M.W., A.I.G., M.S.G.) and Pharmacology (M.L.S., H.F., S.S., N.G.A.), and Division of Nephrology (A.I.G., M.S.G.), New York Medical College, Valhalla, New York; and the Rockefeller University, New York, New York (A.K., N.G.A.)
Alvin I. Goodman
Division of Cardiology (A.L.K., J.A.M., M.W.), Departments of Medicine (A.L.K., S.J.P., J.A.M., M.W., A.I.G., M.S.G.) and Pharmacology (M.L.S., H.F., S.S., N.G.A.), and Division of Nephrology (A.I.G., M.S.G.), New York Medical College, Valhalla, New York; and the Rockefeller University, New York, New York (A.K., N.G.A.)
Michael S. Goligorsky
Division of Cardiology (A.L.K., J.A.M., M.W.), Departments of Medicine (A.L.K., S.J.P., J.A.M., M.W., A.I.G., M.S.G.) and Pharmacology (M.L.S., H.F., S.S., N.G.A.), and Division of Nephrology (A.I.G., M.S.G.), New York Medical College, Valhalla, New York; and the Rockefeller University, New York, New York (A.K., N.G.A.)
Attallah Kappas
Division of Cardiology (A.L.K., J.A.M., M.W.), Departments of Medicine (A.L.K., S.J.P., J.A.M., M.W., A.I.G., M.S.G.) and Pharmacology (M.L.S., H.F., S.S., N.G.A.), and Division of Nephrology (A.I.G., M.S.G.), New York Medical College, Valhalla, New York; and the Rockefeller University, New York, New York (A.K., N.G.A.)
Nader G. Abraham
Division of Cardiology (A.L.K., J.A.M., M.W.), Departments of Medicine (A.L.K., S.J.P., J.A.M., M.W., A.I.G., M.S.G.) and Pharmacology (M.L.S., H.F., S.S., N.G.A.), and Division of Nephrology (A.I.G., M.S.G.), New York Medical College, Valhalla, New York; and the Rockefeller University, New York, New York (A.K., N.G.A.)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleCARDIOVASCULAR
Up-Regulation of Heme Oxygenase Provides Vascular Protection in an Animal Model of Diabetes through Its Antioxidant and Antiapoptotic Effects
Adam L. Kruger, Stephen J. Peterson, Michal L. Schwartzman, Heidi Fusco, John A. McClung, Melvin Weiss, Sylvia Shenouda, Alvin I. Goodman, Michael S. Goligorsky, Attallah Kappas and Nader G. Abraham
Journal of Pharmacology and Experimental Therapeutics December 1, 2006, 319 (3) 1144-1152; DOI: https://doi.org/10.1124/jpet.106.107482
Research ArticleCARDIOVASCULAR
Up-Regulation of Heme Oxygenase Provides Vascular Protection in an Animal Model of Diabetes through Its Antioxidant and Antiapoptotic Effects
Adam L. Kruger, Stephen J. Peterson, Michal L. Schwartzman, Heidi Fusco, John A. McClung, Melvin Weiss, Sylvia Shenouda, Alvin I. Goodman, Michael S. Goligorsky, Attallah Kappas and Nader G. Abraham
Journal of Pharmacology and Experimental Therapeutics December 1, 2006, 319 (3) 1144-1152; DOI: https://doi.org/10.1124/jpet.106.107482
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement